Session Information
AABB Annual Meeting and CTTXPO 2010
Click here to go to the previous page
Where Do We Stand on Granulocyte Transfusion?
Track : TC- Technical/Clinical
Program Code: 9327-TC
Date: Monday, October 11, 2010
Time: 4:00 PM to 5:30 PM  EST
Location: 309
DIRECTOR :
Robertson Davenport, MD, Associate Professor, University of Michigan Hospitals
MODERATOR :
Robertson Davenport, MD, Associate Professor, University of Michigan Hospitals
SPEAKER (S):
Edwin Massey, MB BCh, FRCP, FRCPath, Associate Medical Director for Patient Services, NHS Blood and Transplant, UK
Current Medical Evidence in Granulocyte Transfusion
Thomas H. Price, MD, Medical Director, Puget Sound Blood Center
The RING Trial: Status Update
Description
This session will focus on the current state of granulocyte transfusion. An author of a recent Cochrane Review on granulocyte transfusion, will review the medical evidence supporting the use of granulocytes as well as gaps in our knowledge. The study chair for the RING trial will update the status of clinical trials of granulocyte transfusion.

  • Discuss the current medical evidence of the efficacy of granulocyte transfusions.
  • Identify gaps and weaknesses in the current evidence supporting granulocyte transfusion.
  • State the eligibility criteria, outcome measures, and current status of the RING trial.


CE CategoryCE Value
California Clinical Laboratory Personnel 1.5
California Nurse 1.8
Florida Laboratory Personnel 1.8
General Attendee 1.5
Physician 1.5
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are
the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text
are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or
reproduction of any materials herein is strictly prohibited.